Mechanisms of cannabinoid analgesia

Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential

Volumn , Issue , 2013, Pages 89-100

  Vaughan, Chris W ^a   Christie, MacDonald J ^b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85071764848     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (55)

1. Adams IB, Compton DR, Martin HR. Assessment of anandarnide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. Journal of Pharmacology and Experimental Therapeutics 1998;284(3);1209-1217
2. Bandler R, Shipley MT. Columnar organization in the midbrain periaqueductal gray: Modules for emotional expression? Trends in Neuroscience 1994;17(9):379-389
3. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 1997;277(5329);1094-1097
4. Bieher HI, Mechoulam R. Pharmacological effects of two active constituents ofrnarihuana. Archives Internationales de Pharmacodynamie et de Therapie 1968; 172(1 );24-3l
5. Bloom AS, Dewey WL, Hams LS, Brosius KK. 9-nor-9?-hydroxyhexahydrocannabinol, a cannabinoid with potent antinociceptive activity: Comparisons with morphine. Journal of Pharmacology and Experimental Therapeutics 1977;2002: 263-270
6. 9_tetrahydrocannabinol in the rat and mouse. Psychapharmacolagia 1972;25(3);275-280
7. Calignano A, La Rana G, Giuffrida A, Piomelli D. Control of pain initiation by endogenous cannabinoids. Natllre 1998;394(6690);277-28l
8. Compton DR, Martin SR. The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of ca1U1abim.imetic activity. Journal of Pharmacology and Experimental Therapeu tics 1997;283(3); 1138-1143
9. Connor M, Christie MI. Modulation ofCa2+ channel currents of acutely dissociated rat periaqueductal grey neurons. Journal of Physiology 199R;509(Ptl):47-5R
10. Dajani EZ, Larsen KR, Taylor I, Dajani NE, Shahwan TG, Neeleman SD, Taylor MS, Dayton MT, Mir GN. 1',l'-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: A novel, orally effective cannabinoid with analgesic and antiinflammatory properties.Tournai ofPharmacologv and Experimental Therapeutics 1999;291 (I );31-38
11. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz IC, PiomeUi D. Formation and inactivation of endogenous cannabinoid anandanlide in central neurons. Nature (London) 1994;372(6507);686-691
12. Edsall SA, Knapp RI, Vanderah TW, Roeske WR, Consroe P, Yamamura HI. Antisense oligodeoxynuc1eotide treatment to the brain cannabinoid receptor inhibits antinociception. Neuroreport 1996;7(2);593-596
13. Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Annual Review of Neuroscience 1991;14:219-245
14. Pride E, Mechoulam R. Phannacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. European Journal of Pharmacology 1993;231 (2);313-314
15. Hamann W, di Vadi PP. Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors 11etterl. Lancet 1999;353(9152):560
16. Herkenham M. Lynn AB, Johnson MR, Melvin LS, de Costa BR. Rice KC. Charactel;zation and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. Journal of Neuroscience 1991; 11 (2):563-583
17. Herzberg U, Eliav E, Bennett GJ, Kopin IJ. The analgesic effects of R(+)WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neuroscience Letters 1997;22 1 (2-3): 157-160
18. Hohmann AG, Briley EM, Herkenham M. Pre-and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord. Brain Research 1999; 822(1-2): 17-25
19. Hohmann AG, Herkenham M. Localization of central cannabinoid CB l receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: A double-label in situ hybridization study. Neuroscience 1999;90(3):923-931
20. Holunann AG, Tsou K, Walker JM. Cmmabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal hom of the rat. Journal of Neurophysiology 1999;81(2):575-583
21. Jacob n, Rmnabadran K, Campos-Medeiros M. A pharmacological analysis of levonantradol antinociception in mice. Journal of Clinical Pharmacology 1981; 21 :327S-333S
22. Jaggar SI, Hasnie FS, Sellaturay S, Rice AS. The anti-hyperalgesic actions of the cammbinoid mmndamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain 1998;76(1-2): 189-199
23. Li J, Daughters RS, Bullis C, Bengiamin R, Stucky MW, Brennan J, Simone DA. The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats. Pain 1999;81( 1-2):25-33
24. Lichtmml AH, Cook SA, Martin BR. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: Evidence supporting periaqueductal gray Involvement. Journal of Pharmacologv and Experimental Therapeutics 1996; 276(2):585-593
25. Lichtman AH, Martin BR. Spinal and supraspinal components of cannabinoidinduced antinociception. Journal of Pharmacology and EJ.perimental Therapeuth·s 1991 ;258(2):5 17-523
26. Lichtman AH, Martin BR. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats. Pharmacology, Biochemistry and Behavior 1997;57(1-2):7-12
27. Mailleux P, Vanderhaeghen II. Distribution of neuronal cmmabinoid receptor in the adult rat brain: A comparative receptor binding radioautography mId in situ hybridization histochemistry. Neuroscience 1992;48(3):655-668
28. Martin WJ, Coffin PO, Attias E, Balinsky M, Tsou K, Walker JM. Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections. Brain Research 1999;822(1-2);237-242
29. Martill WI, Hohmann AG, Walker 1M. Suppression of noxious stimulusevoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and anti nociceptive effects. Journal of Neuroscience 1996;16(20):6601-6611
30. Martill WI, Lai NK, Patrick SL, Tsou K, Walker JM. Antinociceptive actions of cannabinoids following intraventricular administration in rats. Brain Research 1993;629(2):300-304
31. Martin WI. Patrick SL. Coffin PO. Tsou K. Walker 1M. An examination of the central sites of action of cannabinoid-induced antinociception in the rat. Life Sciences 1995;56(23-24):2103-2109
32. Matsuda LA, BOlUler TI, Lolait SJ. Localization of cannabinoid receptor mRNA in rat brain.Tournai of Comparative Neurology 1993;327:535-550
33. Mechoulam R. The phannacohistory of Cannabis sativa. In Mechoulam R, ed. Cannabinoids as therapeutic agents. Boca Raton, FL: CRC Press, 1986
34. Meng ID, Manning BH, Martin WJ, Fields HL. An analgesia circuit activated by cannabinoids. Nature (London ) 1998;395(6700):381-383
35. 9-tetrahydrocannabinol as measured with the formalin test. European Journal of Pharmacology 1980;61(3):313-315
36. Osborne PB. Vaughan CW, Wilson HI, Christie MJ. Opioid inhibition of rat periaqueductal grey neurones with identified projections to rostral ventromedial medulla in vitro.Ionrnal of Physiology 1996;490(Pt 2):383-389
37. Pan ZZ, Williams JT, Osbome PB. Opioid actions on single nucleus raphe magnus neurons from rat and guinea pig in vitro. Journal of Physiology 1990; 427:519-532
38. Reche I, Fuentes lA, Ruiz-Gayo M. Potentiation of Δ9-tetrahydrocannabinol induced analgesia by morphine in mice: Involvement of nlU-and kappa-opioid receptors. Enropean.Tonrnal of Pharmacology 1996;318(7): 11-16
39. Richardson JD, Kilo S, Hargreaves KM. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB I receptors. Pain 1998;75(1): 111-119
40. Rinaldi-Cannona M. Barth F. Heaulme M. Shire D. Calandra B. Congy C. Martinez S, MaruaniJ, Neliat G, Caput D, et al. SR 141716A, a potent and selective antagonist of the brain caIlnabinoidreceptor. FEBS Letters 1994;350(2-3):240-244
41. Rinaldi-Cannona M, Barth F, Millan 1, Derocq 1M, Casellas P, Congy C, Oustnc D. Sanan M. Bouaboula M. Calandra B. et al. SR 144528. the first potent and selective antagonist of the CB2 crumabinoid receptor. Journal of Pharmacology and Experimental Therapeutics 1998;284(2):644-650
42. 9-tetrahydrocannabinol. Pharmacology. Biochemistry and Behavior 1998;60(2):559-566
43. Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, Martin BR. The phannacological activity of allalldamide, a putative endogenous c31lllabinoid, in mice. Journal of Pharmacology and Experimental Therapeutics 1994;270(1):219-227
44. 9-THC). Journal of Pharmacology and Erperimental Therapeutics 1973;186(3):646-655
45. Strangman NM, Patrick SL, Hohunann AG, Tsou K, Walker JM. Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity. Brain Research 1998;813(2):323-328
46. Strangman NM, Walker 1M. Cannabinoid WIN 55,212-2 inhibits the activity-dependent facilitation of spinal nociceptive responses. Journal of Neurophysiology 1999;82( I ):472-477
47. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM. Immunohistochemical distribution of cannabinoid CB 1 receptors in the rat central nervous system. Neuroscience 1998;83(2):393-411
48. Vaughan CW, Connor MA, Bagley EE, Christie MI. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal grey neurons in vitro. Molecular Pharmacology 2000;57(2):288-295
49. Vaughan CW, Ingram SL, Connor MA, Christie MI. How opioids inhibit GAB A-mediated neurotransmission. Nature (Londnn) 1997;390(6660):611-614
50. Vaughan CW, McGregor IS, Christie MJ. Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro. British Journal of Pharmacology 1999;127(4):935-940
51. Vivian lA, Kishioka S, Butelman ER, Broadbear I, Lee KO, Woods IH. Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: Antagonist effects of SR 141716A. Journal of Pharmacology and Experimental Therapeutics 1998;286(2):697-703
52. Walker 1M, Huang SM, Strangman NM, Tsou K, Sanudo-Pena Me. Pain modulation by release of the endogenous cannabinoid anandamide. Proceedings of the National Academy or Sciences or the United States orAmerica 1999;96(21):1 2198-12203
53. Welch SP, Stevens DL. Antinociceptive activity of intrathecally administered cammbinoids alone, and in combination with morphine, in mice. Journal of Pharmacology and Experimental Therapeutics 1992;262(1): 10-18
54. Yaksh TL. The antinociceptive effects of intrathecally administered levonantradol and desacetyllevonantradol in the rat. Journal of Clinical Pharmacology 1981;21(8-9 supplement):334S-340S
55. Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner Tl. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB I receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America 1999;96(10):5780-5785